Global Alopecia Drugs Market 2016-2020

Table of Contents

PART 01: Executive summary

• Highlights

PART 02: Scope of the report

• Market overview
• Top-vendor offerings

PART 03: Market research methodology

• Research methodology
• Economic indicators

PART 04: Introduction

• Key market highlights

PART 05: Overview: Alopecia

• Causes of hair loss
• Hair loss: Symptoms and treatment

PART 06: Pipeline portfolio

PART 07: Market landscape

• Market overview
• Five forces analysis

PART 08: Key buying criteria

PART 09: Market segmentation by ROA

• Global topical alopecia drugs market
• Global oral alopecia drugs market
• Global injectable alopecia drugs market

PART 10: Market segmentation by gender

PART 11: Geographical segmentation

• Alopecia drugs market in Americas
• Alopecia drugs market in EMEA
• Alopecia drugs market in APAC

PART 12: Market drivers

• Lifestyle changes
• Popularity of off-label and OTC drugs
• High uptake of approved therapies

PART 13: Impact of drivers

PART 14: Market challenges

• Poor patient adherence
• Preference for alternative therapies
• Limited approved therapies

PART 15: Impact of drivers and challenges

PART 16: Market trends

• Focus on regenerative medicines
• Emergence of laser technology and PRP therapy
• Launch of new products

PART 17: Vendor landscape

• Competitive scenario
• Other prominent vendors

PART 18: Key vendor analysis

• GlaxoSmithKline
• Johnson & Johnson
• Merck

PART 19: Appendix

• List of abbreviations

PART 20: Explore Technavio